| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 3.23e-07 | 3 | 138 | 3 | GO:0004517 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 1.29e-06 | 4 | 138 | 3 | GO:0034617 | |
| GeneOntologyMolecularFunction | NADP binding | 4.37e-06 | 62 | 138 | 6 | GO:0050661 | |
| GeneOntologyMolecularFunction | arginine binding | 2.63e-05 | 9 | 138 | 3 | GO:0034618 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 4.83e-05 | 94 | 138 | 6 | GO:0050660 | |
| GeneOntologyMolecularFunction | FMN binding | 1.69e-04 | 16 | 138 | 3 | GO:0010181 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.14e-04 | 123 | 138 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.07e-04 | 194 | 138 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 4.68e-04 | 5 | 138 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.68e-04 | 93 | 138 | 5 | GO:0097110 | |
| GeneOntologyBiologicalProcess | regulation of system process | CACNA1D GAS6 REN PTGS1 GAL TNNI3K GTF2IRD2B TENM4 NRXN2 NFATC1 CNTNAP2 GTF2IRD2 DLG1 DLG4 NOS1 G6PD NOS3 IL6ST | 2.02e-06 | 734 | 138 | 18 | GO:0044057 |
| GeneOntologyBiologicalProcess | synapse organization | GPHN SORBS2 PPFIBP1 EGLN1 GRID2 LRIT3 NEDD9 TENM4 PLPPR4 NRXN2 SETD5 ARHGEF9 CNTNAP2 DLG1 DLG4 BSN PLXNB1 | 3.40e-06 | 685 | 138 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of guanylate cyclase activity | 5.78e-06 | 6 | 138 | 3 | GO:0031284 | |
| GeneOntologyBiologicalProcess | cell junction organization | GPHN SORBS2 PPFIBP1 EGLN1 GRID2 LRIT3 RCC2 NEDD9 TENM4 PLPPR4 NRXN2 SETD5 ARHGEF9 CNTNAP2 DLG1 DLG4 PEAK1 BSN CDH12 PLXNB1 | 7.67e-06 | 974 | 138 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of guanylate cyclase activity | 1.60e-05 | 8 | 138 | 3 | GO:0031282 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.84e-05 | 24 | 138 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | receptor clustering | 1.99e-05 | 83 | 138 | 6 | GO:0043113 | |
| GeneOntologyBiologicalProcess | arginine catabolic process | 3.40e-05 | 10 | 138 | 3 | GO:0006527 | |
| GeneOntologyBiologicalProcess | postsynapse organization | GPHN SORBS2 GRID2 NEDD9 PLPPR4 NRXN2 ARHGEF9 CNTNAP2 DLG1 DLG4 | 5.00e-05 | 313 | 138 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | regulation of muscle system process | PTGS1 TNNI3K GTF2IRD2B NFATC1 GTF2IRD2 DLG1 NOS1 G6PD NOS3 IL6ST | 5.56e-05 | 317 | 138 | 10 | GO:0090257 |
| GeneOntologyBiologicalProcess | transition between fast and slow fiber | 7.98e-05 | 13 | 138 | 3 | GO:0014883 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 1.14e-04 | 71 | 138 | 5 | GO:0099084 | |
| GeneOntologyBiologicalProcess | cell junction assembly | GRID2 LRIT3 RCC2 NRXN2 SETD5 ARHGEF9 CNTNAP2 DLG1 DLG4 PEAK1 BSN CDH12 PLXNB1 | 1.19e-04 | 569 | 138 | 13 | GO:0034329 |
| GeneOntologyCellularComponent | dendrite | GPHN CACNA1D SORBS2 FAT3 KIF21A GRID2 PTCH1 LRIT3 CNTNAP2 DLG1 DLG4 BSN KIF17 NOS1 INPP5J IL6ST SYNCRIP | 5.18e-05 | 858 | 138 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GPHN CACNA1D SORBS2 FAT3 KIF21A GRID2 PTCH1 LRIT3 CNTNAP2 DLG1 DLG4 BSN KIF17 NOS1 INPP5J IL6ST SYNCRIP | 5.34e-05 | 860 | 138 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | dynein complex | 4.45e-04 | 54 | 138 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GPHN CACNA1D SORBS2 FAT3 KIF21A TRPM2 GRID2 PTCH1 LRIT3 GAL CNTNAP2 DLG1 DLG4 BSN KIF17 NOS1 INPP5J IL6ST SYNCRIP | 4.60e-04 | 1228 | 138 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 6.38e-04 | 6 | 138 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | microtubule associated complex | 7.08e-04 | 161 | 138 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | mRNA editing complex | 8.89e-04 | 7 | 138 | 2 | GO:0045293 | |
| HumanPheno | Short 4th metacarpal | 1.13e-06 | 18 | 57 | 5 | HP:0010044 | |
| HumanPheno | Aplasia/Hypoplasia of the 4th metacarpal | 1.51e-06 | 19 | 57 | 5 | HP:0010042 | |
| HumanPheno | Abnormal 4th metacarpal morphology | 4.23e-06 | 23 | 57 | 5 | HP:0010012 | |
| MousePheno | abnormal brain blood flow rate | 5.28e-07 | 3 | 114 | 3 | MP:0031179 | |
| MousePheno | abnormal myocardial fiber physiology | 8.52e-06 | 90 | 114 | 7 | MP:0004215 | |
| MousePheno | decreased kidney cell proliferation | 4.28e-05 | 9 | 114 | 3 | MP:0011441 | |
| MousePheno | increased heart rate | 5.55e-05 | 120 | 114 | 7 | MP:0002626 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 6.08e-05 | 10 | 114 | 3 | MP:0003434 | |
| MousePheno | absent active-zone-anchored inner hair cell synaptic ribbon | 6.59e-05 | 2 | 114 | 2 | MP:0004563 | |
| MousePheno | abnormal cerebral blood flow rate | 6.59e-05 | 2 | 114 | 2 | MP:0031182 | |
| Domain | NO_synthase | 3.95e-07 | 3 | 138 | 3 | PF02898 | |
| Domain | NOS_euk | 3.95e-07 | 3 | 138 | 3 | IPR012144 | |
| Domain | - | 3.95e-07 | 3 | 138 | 3 | 3.90.340.10 | |
| Domain | NOS_N | 3.95e-07 | 3 | 138 | 3 | IPR004030 | |
| Domain | NOS | 3.95e-07 | 3 | 138 | 3 | PS60001 | |
| Domain | FAD_binding_1 | 7.77e-06 | 6 | 138 | 3 | PF00667 | |
| Domain | - | 7.77e-06 | 6 | 138 | 3 | 1.20.990.10 | |
| Domain | FAD-binding_1 | 7.77e-06 | 6 | 138 | 3 | IPR003097 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 7.77e-06 | 6 | 138 | 3 | IPR023173 | |
| Domain | LAM_G_DOMAIN | 8.45e-06 | 38 | 138 | 5 | PS50025 | |
| Domain | EGF | 9.95e-06 | 235 | 138 | 10 | SM00181 | |
| Domain | Laminin_G_2 | 1.09e-05 | 40 | 138 | 5 | PF02210 | |
| Domain | EGF-like_dom | 1.64e-05 | 249 | 138 | 10 | IPR000742 | |
| Domain | LamG | 1.76e-05 | 44 | 138 | 5 | SM00282 | |
| Domain | Flavodoxin/NO_synth | 2.15e-05 | 8 | 138 | 3 | IPR008254 | |
| Domain | Flavdoxin-like | 2.15e-05 | 8 | 138 | 3 | IPR001094 | |
| Domain | FLAVODOXIN_LIKE | 2.15e-05 | 8 | 138 | 3 | PS50902 | |
| Domain | Flavodoxin_1 | 2.15e-05 | 8 | 138 | 3 | PF00258 | |
| Domain | - | 4.56e-05 | 10 | 138 | 3 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 4.56e-05 | 10 | 138 | 3 | IPR029039 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 4.56e-05 | 10 | 138 | 3 | IPR001709 | |
| Domain | EGF_3 | 6.37e-05 | 235 | 138 | 9 | PS50026 | |
| Domain | Laminin_G | 6.85e-05 | 58 | 138 | 5 | IPR001791 | |
| Domain | OxRdtase_FAD/NAD-bd | 8.27e-05 | 12 | 138 | 3 | IPR001433 | |
| Domain | NAD_binding_1 | 8.27e-05 | 12 | 138 | 3 | PF00175 | |
| Domain | EGF_1 | 1.19e-04 | 255 | 138 | 9 | PS00022 | |
| Domain | EGF-like_CS | 1.42e-04 | 261 | 138 | 9 | IPR013032 | |
| Domain | EGF_2 | 1.59e-04 | 265 | 138 | 9 | PS01186 | |
| Domain | - | 3.22e-04 | 4 | 138 | 2 | 3.90.1460.10 | |
| Domain | MAGUK_N_PEST | 3.22e-04 | 4 | 138 | 2 | PF10608 | |
| Domain | PDZ_assoc | 3.22e-04 | 4 | 138 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 3.22e-04 | 4 | 138 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 3.22e-04 | 4 | 138 | 2 | IPR019583 | |
| Domain | MAGUK_N_PEST | 3.22e-04 | 4 | 138 | 2 | SM01277 | |
| Domain | DLG1 | 3.22e-04 | 4 | 138 | 2 | IPR016313 | |
| Domain | GTF2I | 3.22e-04 | 4 | 138 | 2 | PS51139 | |
| Domain | GTF2I | 3.22e-04 | 4 | 138 | 2 | PF02946 | |
| Domain | GTF2I | 3.22e-04 | 4 | 138 | 2 | IPR004212 | |
| Domain | Fd_Rdtase_FAD-bd | 3.51e-04 | 19 | 138 | 3 | IPR017927 | |
| Domain | PLAC | 3.51e-04 | 19 | 138 | 3 | PS50900 | |
| Domain | FAD_FR | 3.51e-04 | 19 | 138 | 3 | PS51384 | |
| Domain | PLAC | 3.51e-04 | 19 | 138 | 3 | IPR010909 | |
| Domain | Pyr_redox_2 | 3.51e-04 | 19 | 138 | 3 | PF07992 | |
| Domain | Riboflavin_synthase-like_b-brl | 3.51e-04 | 19 | 138 | 3 | IPR017938 | |
| Domain | EGF_CA | 4.41e-04 | 86 | 138 | 5 | PF07645 | |
| Domain | HnRNP_R/Q_splicing_fac | 5.34e-04 | 5 | 138 | 2 | IPR006535 | |
| Domain | - | 6.97e-04 | 95 | 138 | 5 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 7.66e-04 | 97 | 138 | 5 | IPR018097 | |
| Domain | EGF_CA | 8.40e-04 | 99 | 138 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 8.79e-04 | 100 | 138 | 5 | PS00010 | |
| Domain | Gal_Oxase/kelch_b-propeller | 9.48e-04 | 59 | 138 | 4 | IPR011043 | |
| Domain | Growth_fac_rcpt_ | 1.07e-03 | 156 | 138 | 6 | IPR009030 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.14e-03 | 106 | 138 | 5 | IPR000152 | |
| Domain | Kelch_1 | 1.79e-03 | 70 | 138 | 4 | PF01344 | |
| Domain | Kelch_1 | 1.79e-03 | 70 | 138 | 4 | IPR006652 | |
| Domain | EGF_CA | 2.13e-03 | 122 | 138 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.28e-03 | 124 | 138 | 5 | IPR001881 | |
| Domain | TPR_7 | 2.35e-03 | 10 | 138 | 2 | PF13176 | |
| Domain | EGF | 2.45e-03 | 126 | 138 | 5 | PF00008 | |
| Domain | ABC_A | 3.41e-03 | 12 | 138 | 2 | IPR026082 | |
| Domain | ABC_transporter_CS | 3.67e-03 | 42 | 138 | 3 | IPR017871 | |
| Domain | PLAC | 4.65e-03 | 14 | 138 | 2 | PF08686 | |
| Domain | Neurexin-like | 4.65e-03 | 14 | 138 | 2 | IPR003585 | |
| Domain | 4.1m | 4.65e-03 | 14 | 138 | 2 | SM00294 | |
| Domain | ABC_tran | 5.35e-03 | 48 | 138 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.35e-03 | 48 | 138 | 3 | PS50893 | |
| Domain | SH3 | 5.42e-03 | 216 | 138 | 6 | SM00326 | |
| Domain | SH3 | 5.42e-03 | 216 | 138 | 6 | PS50002 | |
| Domain | ABC_TRANSPORTER_1 | 5.67e-03 | 49 | 138 | 3 | PS00211 | |
| Domain | SH3_domain | 5.92e-03 | 220 | 138 | 6 | IPR001452 | |
| Domain | ABC_transporter-like | 6.00e-03 | 50 | 138 | 3 | IPR003439 | |
| Domain | Guanylate_kinase_CS | 6.08e-03 | 16 | 138 | 2 | IPR020590 | |
| Domain | TPR_8 | 7.06e-03 | 53 | 138 | 3 | PF13181 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.71e-05 | 22 | 102 | 4 | M915 | |
| Pathway | WP_EFFECTS_OF_NITRIC_OXIDE | 2.01e-05 | 8 | 102 | 3 | M39677 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 2.17e-05 | 47 | 102 | 5 | M39531 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GPHN SORBS2 REN FAAH2 NRXN2 CNTNAP2 DLG1 DLG4 NOS1 NOS2 NOS3 | 6.86e-05 | 367 | 102 | 11 | M48346 |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 9.98e-05 | 13 | 102 | 3 | MM15015 | |
| Pathway | WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS | 9.98e-05 | 13 | 102 | 3 | M39894 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.22e-04 | 67 | 102 | 5 | MM15327 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.05e-08 | 67 | 140 | 7 | 16987237 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10068656 | ||
| Pubmed | Crucial roles of nitric oxide synthases in β-adrenoceptor-mediated bladder relaxation in mice. | 6.38e-08 | 3 | 140 | 3 | 27784691 | |
| Pubmed | Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy. | 6.38e-08 | 3 | 140 | 3 | 11717657 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 15242984 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 14551061 | ||
| Pubmed | Nitric oxide synthases and heart failure - lessons from genetically manipulated mice. | 6.38e-08 | 3 | 140 | 3 | 23774658 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10443886 | ||
| Pubmed | Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. | 6.38e-08 | 3 | 140 | 3 | 14665440 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 24192154 | ||
| Pubmed | Deletion of neuronal NOS prevents impaired vasodilation in septic mouse skeletal muscle. | 6.38e-08 | 3 | 140 | 3 | 17258180 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 15856945 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 18465682 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 8995432 | ||
| Pubmed | nNOS deficiency-induced cell proliferation depletes the neurogenic reserve. | 6.38e-08 | 3 | 140 | 3 | 22027181 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 16950998 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 25389974 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 25902315 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 15180967 | ||
| Pubmed | Alterations in nitric oxide synthase isoforms in acute lower limb ischemia and reperfusion. | 6.38e-08 | 3 | 140 | 3 | 18024942 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 21204701 | ||
| Pubmed | Nitric oxide synthase in the vestibulocochlear system of mice. | 6.38e-08 | 3 | 140 | 3 | 9824677 | |
| Pubmed | Exhaled nitric oxide production by nitric oxide synthase-deficient mice. | 6.38e-08 | 3 | 140 | 3 | 11029328 | |
| Pubmed | Cardiovascular and renal control in NOS-deficient mouse models. | 6.38e-08 | 3 | 140 | 3 | 12571071 | |
| Pubmed | Decreased viability of nitric oxide synthase double knockout mice. | 6.38e-08 | 3 | 140 | 3 | 12704728 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 21722677 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 23434456 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 11920687 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 17492662 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10330441 | ||
| Pubmed | Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. | 6.38e-08 | 3 | 140 | 3 | 17395508 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 20060328 | ||
| Pubmed | Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. | 6.38e-08 | 3 | 140 | 3 | 8943206 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 21756313 | ||
| Pubmed | Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. | 6.38e-08 | 3 | 140 | 3 | 18695006 | |
| Pubmed | Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. | 6.38e-08 | 3 | 140 | 3 | 16024729 | |
| Pubmed | Nitric oxide synthase expression and role during cardiomyogenesis. | 6.38e-08 | 3 | 140 | 3 | 10690339 | |
| Pubmed | Molecular control of nitric oxide synthases in the cardiovascular system. | 6.38e-08 | 3 | 140 | 3 | 10690323 | |
| Pubmed | Hypoxic vasodilation by red blood cells: evidence for an s-nitrosothiol-based signal. | 6.38e-08 | 3 | 140 | 3 | 18658051 | |
| Pubmed | Expression of nitric oxide synthases in leukocytes in nasal polyps. | 6.38e-08 | 3 | 140 | 3 | 22374200 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 25366612 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 12562678 | ||
| Pubmed | Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. | 6.38e-08 | 3 | 140 | 3 | 21890687 | |
| Pubmed | Nitric oxide synthase isoforms play distinct roles during acute peritonitis. | 6.38e-08 | 3 | 140 | 3 | 19706695 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 25125509 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10484454 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 8806629 | ||
| Pubmed | Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice. | 6.38e-08 | 3 | 140 | 3 | 19407124 | |
| Pubmed | Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. | 6.38e-08 | 3 | 140 | 3 | 9870939 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 20304785 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 34299181 | ||
| Pubmed | Obesity, insulin resistance, and skeletal muscle nitric oxide synthase. | 6.38e-08 | 3 | 140 | 3 | 22797309 | |
| Pubmed | Association between achalasia and nitric oxide synthase gene polymorphisms. | 6.38e-08 | 3 | 140 | 3 | 16848803 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 9410890 | ||
| Pubmed | Cellular and molecular mechanisms of endothelial cell dysfunction. | 6.38e-08 | 3 | 140 | 3 | 9410891 | |
| Pubmed | Nitric oxide synthase gene polymorphisms in functional dyspepsia. | 6.38e-08 | 3 | 140 | 3 | 24114042 | |
| Pubmed | Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. | 6.38e-08 | 3 | 140 | 3 | 10516139 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 11058547 | ||
| Pubmed | Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. | 6.38e-08 | 3 | 140 | 3 | 10362674 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 18433298 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10966931 | ||
| Pubmed | Substance P enhances wound closure in nitric oxide synthase knockout mice. | 6.38e-08 | 3 | 140 | 3 | 18952239 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10556946 | ||
| Pubmed | Nitric oxide synthase isoforms undertake unique roles during excitotoxicity. | 6.38e-08 | 3 | 140 | 3 | 17446423 | |
| Pubmed | Permissive role of nitric oxide in macula densa control of renin secretion. | 6.38e-08 | 3 | 140 | 3 | 15075180 | |
| Pubmed | Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice. | 6.38e-08 | 3 | 140 | 3 | 25017185 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 20953358 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 12816735 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 20581102 | ||
| Pubmed | Expression profiles of NOS isoforms in gingiva of nNOS knockout mice. | 6.38e-08 | 3 | 140 | 3 | 24657074 | |
| Pubmed | Vascular biology in genetically altered mice : smaller vessels, bigger insight. | 6.38e-08 | 3 | 140 | 3 | 10590250 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 35772285 | ||
| Pubmed | Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period. | 6.38e-08 | 3 | 140 | 3 | 24305053 | |
| Pubmed | Lessons learned from nitric oxide synthase knockout animals. | 6.38e-08 | 3 | 140 | 3 | 10709868 | |
| Pubmed | Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization. | 6.38e-08 | 3 | 140 | 3 | 25813085 | |
| Pubmed | Limb reduction defects in endothelial nitric oxide synthase-deficient mice. | 6.38e-08 | 3 | 140 | 3 | 9843834 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 9843821 | ||
| Pubmed | Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. | 6.38e-08 | 3 | 140 | 3 | 18413498 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 20739607 | ||
| Pubmed | Expression of nitric oxide synthase isoforms in human pregnant myometrium at term. | 6.38e-08 | 3 | 140 | 3 | 12445599 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 19089323 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 23572278 | ||
| Pubmed | Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. | 6.38e-08 | 3 | 140 | 3 | 10203575 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 16087361 | ||
| Pubmed | Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis. | 6.38e-08 | 3 | 140 | 3 | 23826716 | |
| Pubmed | Analysis of 16 STRs of NOS gene regions and around in six Sardinian populations (Italy). | 6.38e-08 | 3 | 140 | 3 | 24573959 | |
| Pubmed | [Role of nitric oxide synthases in the pathogenesis of cardiovascular disease]. | 6.38e-08 | 3 | 140 | 3 | 24813792 | |
| Pubmed | Analysis of nitric oxide synthase genes in cluster headache. | 6.38e-08 | 3 | 140 | 3 | 12421162 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 20232214 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 10891583 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 15217783 | ||
| Pubmed | Differential roles of nitric oxide synthases in regulation of ultraviolet B light-induced apoptosis. | 6.38e-08 | 3 | 140 | 3 | 20547234 | |
| Pubmed | Transient expression of NOS-II during development of the murine enteric nervous system. | 2.55e-07 | 4 | 140 | 3 | 15609086 | |
| Pubmed | Control of disease tolerance to malaria by nitric oxide and carbon monoxide. | 2.55e-07 | 4 | 140 | 3 | 24981859 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 22486744 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 16226732 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 25892053 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 16733795 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 12438451 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 19766235 | ||
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.87e-06 | 208 | 140 | 9 | M39233 | |
| Coexpression | NABA_ECM_REGULATORS | 5.63e-06 | 238 | 140 | 9 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 6.44e-06 | 242 | 140 | 9 | MM17062 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 9.20e-06 | 137 | 140 | 7 | M39241 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | 3.46e-05 | 69 | 140 | 5 | M45681 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL | 3.97e-05 | 71 | 140 | 5 | M45677 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | PCED1A CACNA1D FAT4 TCF3 CAND2 TTC28 ADAMTS3 FAT3 PCDHB7 PELI2 GRID2 PTCH1 NEDD9 TENM4 GLI3 ARHGEF9 IL6ST | 2.35e-05 | 806 | 140 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.46e-05 | 243 | 140 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-08 | 175 | 141 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-07 | 183 | 141 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-07 | 189 | 141 | 8 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.01e-07 | 194 | 141 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.09e-07 | 195 | 141 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.26e-07 | 197 | 141 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.26e-07 | 197 | 141 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 199 | 141 | 8 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.09e-07 | 139 | 141 | 7 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-06 | 181 | 141 | 7 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.51e-06 | 190 | 141 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-06 | 191 | 141 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-06 | 191 | 141 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 195 | 141 | 7 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.30e-06 | 198 | 141 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.37e-06 | 128 | 141 | 6 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.78e-06 | 148 | 141 | 6 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.78e-06 | 148 | 141 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.09e-06 | 149 | 141 | 6 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.09e-06 | 149 | 141 | 6 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 157 | 141 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 159 | 141 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 162 | 141 | 6 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 167 | 141 | 6 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 169 | 141 | 6 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 1.83e-05 | 172 | 141 | 6 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.95e-05 | 174 | 141 | 6 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 176 | 141 | 6 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 176 | 141 | 6 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-05 | 176 | 141 | 6 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 179 | 141 | 6 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 181 | 141 | 6 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 182 | 141 | 6 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 182 | 141 | 6 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-05 | 183 | 141 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.67e-05 | 184 | 141 | 6 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 185 | 141 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-05 | 186 | 141 | 6 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 186 | 141 | 6 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 186 | 141 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 187 | 141 | 6 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.93e-05 | 187 | 141 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 188 | 141 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 188 | 141 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-05 | 188 | 141 | 6 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 188 | 141 | 6 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.02e-05 | 188 | 141 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 188 | 141 | 6 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 3.11e-05 | 189 | 141 | 6 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| ToppCell | Neuronal_cells|World / Lineage and Cell class | 3.11e-05 | 189 | 141 | 6 | 3948775a0ebd4b32c1623d5487f5581e6e2934d7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.11e-05 | 189 | 141 | 6 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.11e-05 | 189 | 141 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 190 | 141 | 6 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 190 | 141 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-05 | 190 | 141 | 6 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 190 | 141 | 6 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 190 | 141 | 6 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 191 | 141 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-05 | 192 | 141 | 6 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-05 | 192 | 141 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-05 | 192 | 141 | 6 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-05 | 192 | 141 | 6 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.49e-05 | 193 | 141 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.49e-05 | 193 | 141 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.49e-05 | 193 | 141 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.49e-05 | 193 | 141 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-05 | 194 | 141 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.60e-05 | 194 | 141 | 6 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-05 | 194 | 141 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.60e-05 | 194 | 141 | 6 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.70e-05 | 195 | 141 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-05 | 196 | 141 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.81e-05 | 196 | 141 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-05 | 197 | 141 | 6 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.92e-05 | 197 | 141 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-05 | 197 | 141 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.92e-05 | 197 | 141 | 6 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-05 | 198 | 141 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-05 | 198 | 141 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 4.14e-05 | 199 | 141 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.14e-05 | 199 | 141 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | distal-Endothelial-Vein|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.26e-05 | 200 | 141 | 6 | 6acf7afe122f81a95c4c66f4d0878d997b57127a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.35e-05 | 122 | 141 | 5 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| Drug | 3-Bromo-7-Nitroindazole | 2.28e-07 | 3 | 140 | 3 | DB01997 | |
| Drug | N-(3-(Aminomethyl)Benzyl)Acetamidine | 2.28e-07 | 3 | 140 | 3 | DB02044 | |
| Drug | oroxylin A | 5.92e-07 | 27 | 140 | 5 | CID005320315 | |
| Drug | (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin | 9.06e-07 | 4 | 140 | 3 | DB02692 | |
| Drug | N-Omega-Hydroxy-L-Arginine | 9.06e-07 | 4 | 140 | 3 | DB03144 | |
| Drug | T6-7 | 1.31e-06 | 14 | 140 | 4 | CID000216324 | |
| Drug | AC1L1I2J | 1.44e-06 | 32 | 140 | 5 | CID000004395 | |
| Drug | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 2.26e-06 | 5 | 140 | 3 | ctd:C478738 | |
| Drug | 6-formylpterin | 3.92e-06 | 18 | 140 | 4 | CID000150847 | |
| Drug | 1-TRIM | 3.92e-06 | 18 | 140 | 4 | CID000001359 | |
| Drug | 2,3-diaminonaphthalene | 3.92e-06 | 18 | 140 | 4 | CID000069872 | |
| Drug | 4-hydroxy-3-nitrophenylacetyl (NP) caproic | 3.92e-06 | 18 | 140 | 4 | CID000444167 | |
| Drug | Heme | 3.92e-06 | 18 | 140 | 4 | DB03014 | |
| Drug | PTIO | 3.98e-06 | 39 | 140 | 5 | CID002733513 | |
| Drug | N-nitroso-L-arginine | 4.49e-06 | 6 | 140 | 3 | CID000127762 | |
| Drug | NapNa | 4.49e-06 | 6 | 140 | 3 | CID000128726 | |
| Drug | 1-hexacosanol | 4.49e-06 | 6 | 140 | 3 | ctd:C051942 | |
| Drug | anemonin | 4.49e-06 | 6 | 140 | 3 | CID000010496 | |
| Drug | NOC-7 | 4.94e-06 | 19 | 140 | 4 | CID000001383 | |
| Drug | 2-deoxy-D-galactopyranose | 5.37e-06 | 110 | 140 | 7 | CID000000040 | |
| Drug | AC1NLRUC | 7.82e-06 | 7 | 140 | 3 | CID004988604 | |
| Drug | 7-NI | 8.67e-06 | 78 | 140 | 6 | CID000001893 | |
| Drug | periodate-oxidized adenosine | 8.81e-06 | 219 | 140 | 9 | ctd:C027579 | |
| Drug | mesoporphyrin | 9.16e-06 | 46 | 140 | 5 | CID000072422 | |
| Drug | DAF-FM | 9.19e-06 | 22 | 140 | 4 | CID010431792 | |
| Drug | cilazaprilat | 1.11e-05 | 23 | 140 | 4 | CID000064766 | |
| Drug | AC1L1ICV | 1.11e-05 | 23 | 140 | 4 | CID000004522 | |
| Drug | AC1L1ICD | 1.11e-05 | 23 | 140 | 4 | CID000004516 | |
| Drug | L-stylopine | 1.25e-05 | 8 | 140 | 3 | CID000006770 | |
| Drug | N-methyl-DL-aspartic acid | GPHN ONECUT2 CACNA1D GRID2 PTCH1 PTGS1 AIFM1 DLG1 DLG4 PRKG2 BSN KIF17 NOS1 NOS2 NOS3 | 1.29e-05 | 655 | 140 | 15 | CID000004376 |
| Drug | TMB-8 | 1.36e-05 | 176 | 140 | 8 | CID000005494 | |
| Drug | KW-3049 | 1.39e-05 | 50 | 140 | 5 | CID000002324 | |
| Drug | angiotensin (1-7) | 1.53e-05 | 51 | 140 | 5 | CID000123805 | |
| Drug | triflusal | 1.57e-05 | 25 | 140 | 4 | CID000009458 | |
| Drug | 2bkt | 1.69e-05 | 52 | 140 | 5 | CID011840980 | |
| Drug | 3-morpholinosydnonimine (SIN-1 | 1.74e-05 | 88 | 140 | 6 | CID000005219 | |
| Drug | cromakalim | 1.74e-05 | 88 | 140 | 6 | CID000071191 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 1.83e-05 | 302 | 140 | 10 | ctd:D003633 | |
| Drug | diethylamine | 1.85e-05 | 53 | 140 | 5 | CID000008021 | |
| Drug | Vi-o | 1.86e-05 | 9 | 140 | 3 | CID005289554 | |
| Drug | ptaquiloside | 1.87e-05 | 133 | 140 | 7 | ctd:C043680 | |
| Drug | ramiprilat | 2.22e-05 | 55 | 140 | 5 | CID005464096 | |
| Drug | S-nitrosocysteine | 2.39e-05 | 93 | 140 | 6 | CID003359494 | |
| Drug | corticosterone | CYP27A1 REN PTGS1 TNFSF4 GAL SMARCA2 NOS1 NOS2 G6PD NOS3 IL6ST | 2.46e-05 | 381 | 140 | 11 | CID000005753 |
| Drug | glibenclamide | CACNA1D ABCA3 ABCA10 PTGS1 GAL LPA PRKG2 NOS1 NOS2 NOS3 CRTC2 | 2.52e-05 | 382 | 140 | 11 | CID000003488 |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.55e-05 | 192 | 140 | 8 | 3469_DN | |
| Drug | dihydroethidium | 2.69e-05 | 95 | 140 | 6 | CID000128682 | |
| Drug | U-37883A | 2.89e-05 | 29 | 140 | 4 | CID000064392 | |
| Drug | DE gel | 2.98e-05 | 143 | 140 | 7 | CID000008146 | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 4299_UP | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.30e-05 | 199 | 140 | 8 | 4261_DN | |
| Drug | N(G)-nitro-L-arginine methyl ester | 3.40e-05 | 146 | 140 | 7 | CID000003864 | |
| Drug | 17-ODYA | 3.41e-05 | 60 | 140 | 5 | CID000001449 | |
| Drug | guanidinoglutaric acid | 3.62e-05 | 11 | 140 | 3 | CID000002105 | |
| Drug | cetraxate | 3.62e-05 | 11 | 140 | 3 | CID000002680 | |
| Drug | arginine methyl ester | 3.69e-05 | 61 | 140 | 5 | CID000092932 | |
| Drug | L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide | 3.75e-05 | 2 | 140 | 2 | DB01821 | |
| Drug | N,N-dimethylarginine | 3.75e-05 | 2 | 140 | 2 | DB01686 | |
| Drug | [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-4-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-3,6-dimethyloxan-2-yl]oxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate | 3.75e-05 | 2 | 140 | 2 | CID011972312 | |
| Drug | 6 Ni | 3.75e-05 | 2 | 140 | 2 | CID000024239 | |
| Drug | N-Omega-Propyl-L-Arginine | 3.75e-05 | 2 | 140 | 2 | DB02644 | |
| Drug | S-Ethyl-N-Phenyl-Isothiourea | 3.75e-05 | 2 | 140 | 2 | DB03707 | |
| Drug | 82570-34-1 | 3.75e-05 | 2 | 140 | 2 | CID000174280 | |
| Drug | N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE | 3.75e-05 | 2 | 140 | 2 | DB08018 | |
| Drug | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine | 3.75e-05 | 2 | 140 | 2 | DB08019 | |
| Drug | 3 h x | 3.75e-05 | 2 | 140 | 2 | CID016058621 | |
| Drug | DB02077 | 3.75e-05 | 2 | 140 | 2 | CID000656912 | |
| Drug | AC1LCVOW | 3.75e-05 | 2 | 140 | 2 | CID000656910 | |
| Drug | 5-nitroindazole | 3.75e-05 | 2 | 140 | 2 | CID000021501 | |
| Drug | AC1NRAON | 3.75e-05 | 2 | 140 | 2 | CID005288020 | |
| Drug | DB07388 | 3.75e-05 | 2 | 140 | 2 | CID011149707 | |
| Drug | AC1L96OZ | 3.75e-05 | 2 | 140 | 2 | CID000439092 | |
| Drug | AC1NRAUH | 3.75e-05 | 2 | 140 | 2 | CID005288100 | |
| Drug | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | 3.75e-05 | 2 | 140 | 2 | DB07388 | |
| Drug | NSC-10379 | 3.75e-05 | 2 | 140 | 2 | CID000223131 | |
| Drug | 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE | 3.75e-05 | 2 | 140 | 2 | DB07244 | |
| Drug | hard metal | 3.75e-05 | 2 | 140 | 2 | ctd:C080121 | |
| Drug | Ethylisothiourea | 3.75e-05 | 2 | 140 | 2 | DB02234 | |
| Drug | 7-Nitroindazole | 3.75e-05 | 2 | 140 | 2 | DB02207 | |
| Drug | L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide | 3.75e-05 | 2 | 140 | 2 | DB02077 | |
| Drug | N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine | 3.75e-05 | 2 | 140 | 2 | DB03449 | |
| Drug | N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine | 3.75e-05 | 2 | 140 | 2 | DB02027 | |
| Drug | 5-Nitroindazole | 3.75e-05 | 2 | 140 | 2 | DB04534 | |
| Drug | 6-Nitroindazole | 3.75e-05 | 2 | 140 | 2 | DB03100 | |
| Drug | soyasaponin II | 3.75e-05 | 2 | 140 | 2 | ctd:C106126 | |
| Drug | Nitroarginine | 3.75e-05 | 2 | 140 | 2 | DB04223 | |
| Drug | mg X | 3.79e-05 | 31 | 140 | 4 | CID000010111 | |
| Drug | AC1O3MDH | 4.03e-05 | 102 | 140 | 6 | CID006332158 | |
| Drug | cortisone | 4.25e-05 | 103 | 140 | 6 | CID000222786 | |
| Drug | acetaminophen | 4.60e-05 | 270 | 140 | 9 | CID000001983 | |
| Drug | LY83583 | 4.74e-05 | 105 | 140 | 6 | CID000003976 | |
| Drug | B-H-H | 4.81e-05 | 12 | 140 | 3 | CID000447030 | |
| Drug | L-Citrulline | 4.81e-05 | 12 | 140 | 3 | DB00155 | |
| Drug | thaliporphine | 4.81e-05 | 12 | 140 | 3 | CID000100020 | |
| Drug | palytoxin | 4.88e-05 | 33 | 140 | 4 | ctd:C010272 | |
| Drug | procymidone | 4.99e-05 | 155 | 140 | 7 | ctd:C035988 | |
| Drug | bosentan | 5.00e-05 | 106 | 140 | 6 | CID000104865 | |
| Drug | 6-keto-prostaglandin F1 alpha | 5.02e-05 | 65 | 140 | 5 | CID000001866 | |
| Drug | superoxide | NTHL1 REN PTGS1 PARP10 GTF2IRD2B AIFM1 GLI3 GTF2IRD2 NOS1 NOS2 G6PD NOS3 | 5.22e-05 | 490 | 140 | 12 | CID000520535 |
| Drug | AC1L1EDT | 5.50e-05 | 34 | 140 | 4 | CID000002751 | |
| Disease | cognitive function measurement | CACNA1D KLHL2 DPYD A1CF ANKFY1 TTC28 POU3F2 GRID2 TSC22D2 DPP8 PTCH1 CSMD3 LRP1B PRPF18 NEDD9 TNNI3K GANAB TENM4 GLI3 ZMIZ2 PCSK6 DNAI4 PCYOX1 | 1.46e-07 | 1434 | 135 | 23 | EFO_0008354 |
| Disease | Alzheimer's disease (is_marker_for) | 3.02e-06 | 257 | 135 | 9 | DOID:10652 (is_marker_for) | |
| Disease | apolipoprotein B measurement | DNAJC13 A1CF GALK1 GAS6 BCAT2 ABCA10 PARP10 LPA PCSK6 MITF DLG4 NUP93 NSMAF | 1.18e-05 | 663 | 135 | 13 | EFO_0004615 |
| Disease | Bipolar Disorder | CACNA1D TRPM2 POU3F2 REN ITIH3 GAL TENM4 CNTNAP2 DLG4 G6PD NOS3 | 1.30e-05 | 477 | 135 | 11 | C0005586 |
| Disease | creatinine measurement | DNAJC13 A1CF CAND2 MZB1 EGLN1 OBSCN BRWD3 NRXN2 NFATC1 LPA MITF DNAI4 DLG1 CFAP70 BSN CTSS | 1.34e-05 | 995 | 135 | 16 | EFO_0004518 |
| Disease | congenital nonspherocytic hemolytic anemia (implicated_via_orthology) | 2.08e-05 | 2 | 135 | 2 | DOID:2861 (implicated_via_orthology) | |
| Disease | 3-methylhistidine measurement | 2.08e-05 | 2 | 135 | 2 | EFO_0021004 | |
| Disease | Colorectal Carcinoma | DPYD TCF3 ABCA3 NTHL1 OBSCN HAT1 GRID2 CSMD3 ABCA10 TNNI3K NFATC1 GLI3 IL6ST | 2.15e-05 | 702 | 135 | 13 | C0009402 |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 4.09e-05 | 15 | 135 | 3 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Intestinal Perforation | 6.21e-05 | 3 | 135 | 2 | C0021845 | |
| Disease | Hennekam syndrome (is_implicated_in) | 6.21e-05 | 3 | 135 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 6.21e-05 | 3 | 135 | 2 | C0340834 | |
| Disease | Gastric ulcer | 7.27e-05 | 18 | 135 | 3 | C0038358 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 7.57e-05 | 49 | 135 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Hepatomegaly | 1.11e-04 | 54 | 135 | 4 | C0019209 | |
| Disease | pulmonary edema (biomarker_via_orthology) | 1.24e-04 | 4 | 135 | 2 | DOID:11396 (biomarker_via_orthology) | |
| Disease | diabetic angiopathy (biomarker_via_orthology) | 1.24e-04 | 4 | 135 | 2 | DOID:11713 (biomarker_via_orthology) | |
| Disease | impotence (biomarker_via_orthology) | 1.35e-04 | 22 | 135 | 3 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Atherosclerosis | 1.57e-04 | 59 | 135 | 4 | C0004153 | |
| Disease | Atherogenesis | 1.57e-04 | 59 | 135 | 4 | C1563937 | |
| Disease | free cholesterol measurement | 1.76e-04 | 113 | 135 | 5 | EFO_0008591 | |
| Disease | renal hypertension (implicated_via_orthology) | 2.06e-04 | 5 | 135 | 2 | DOID:1073 (implicated_via_orthology) | |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 2.06e-04 | 5 | 135 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.51e-04 | 122 | 135 | 5 | EFO_0004318, EFO_0007789 | |
| Disease | lissencephaly (implicated_via_orthology) | 2.53e-04 | 27 | 135 | 3 | DOID:0050453 (implicated_via_orthology) | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.78e-04 | 274 | 135 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.82e-04 | 28 | 135 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | visceral:subcutaneous adipose tissue ratio | 3.04e-04 | 70 | 135 | 4 | EFO_0004767 | |
| Disease | Hyperekplexia | 3.08e-04 | 6 | 135 | 2 | cv:C0234166 | |
| Disease | Manic Disorder | 3.21e-04 | 71 | 135 | 4 | C0024713 | |
| Disease | coronary artery disease | DPYD FAT4 DNAJC13 HTRA1 SORBS2 ADAMTS3 NEDD9 FNDC1 LPA AGXT MITF BSN NOS3 CTSS ANKS1A | 3.84e-04 | 1194 | 135 | 15 | EFO_0001645 |
| Disease | Infection | 4.30e-04 | 7 | 135 | 2 | C3714514 | |
| Disease | Manic | 4.60e-04 | 78 | 135 | 4 | C0338831 | |
| Disease | parental longevity | 4.67e-04 | 494 | 135 | 9 | EFO_0007796 | |
| Disease | Depression, Bipolar | 4.83e-04 | 79 | 135 | 4 | C0005587 | |
| Disease | benign neoplasm (implicated_via_orthology) | 5.71e-04 | 8 | 135 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Allodynia | 6.09e-04 | 84 | 135 | 4 | C0458247 | |
| Disease | Mechanical Allodynia | 6.09e-04 | 84 | 135 | 4 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 6.09e-04 | 84 | 135 | 4 | C0751212 | |
| Disease | Hyperalgesia, Primary | 6.09e-04 | 84 | 135 | 4 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 6.09e-04 | 84 | 135 | 4 | C0751214 | |
| Disease | Tactile Allodynia | 6.09e-04 | 84 | 135 | 4 | C0751213 | |
| Disease | Hyperalgesia | 6.09e-04 | 84 | 135 | 4 | C0020429 | |
| Disease | Autism Spectrum Disorders | 6.37e-04 | 85 | 135 | 4 | C1510586 | |
| Disease | Hepatic Insufficiency | 7.32e-04 | 9 | 135 | 2 | C1306571 | |
| Disease | Reperfusion Injury | 7.57e-04 | 89 | 135 | 4 | C0035126 | |
| Disease | Schizophrenia | DPYD ADAMTS3 PTGS1 ITIH3 TENM4 NRXN2 CNTNAP2 SMARCA2 DLG1 DLG4 KIF17 NOS1 | 7.66e-04 | 883 | 135 | 12 | C0036341 |
| Disease | smoking cessation | 7.67e-04 | 325 | 135 | 7 | EFO_0004319 | |
| Disease | alkaline phosphatase measurement | ONECUT2 DNAJC13 GAS6 BCAT2 PTCH1 ITIH3 NFATC1 GLI3 MITF DLG4 KIF17 ADAMTSL2 PCYOX1 | 7.99e-04 | 1015 | 135 | 13 | EFO_0004533 |
| Disease | 3-methyl-2-oxobutyrate measurement | 9.13e-04 | 10 | 135 | 2 | EFO_0021020 | |
| Disease | epilepsy (implicated_via_orthology) | 9.41e-04 | 163 | 135 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Cleft palate, isolated | 9.44e-04 | 42 | 135 | 3 | C1837218 | |
| Disease | Myocardial Infarction | 9.67e-04 | 95 | 135 | 4 | C0027051 | |
| Disease | JT interval | 1.01e-03 | 248 | 135 | 6 | EFO_0007885 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.01e-03 | 43 | 135 | 3 | EFO_0022254 | |
| Disease | Diabetes, Autoimmune | 1.08e-03 | 44 | 135 | 3 | C0205734 | |
| Disease | Brittle diabetes | 1.08e-03 | 44 | 135 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 1.08e-03 | 44 | 135 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 1.08e-03 | 44 | 135 | 3 | C3837958 | |
| Disease | Semantic-Pragmatic Disorder | 1.11e-03 | 11 | 135 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 1.11e-03 | 11 | 135 | 2 | C0751257 | |
| Disease | Language Delay | 1.11e-03 | 11 | 135 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.11e-03 | 11 | 135 | 2 | C0023014 | |
| Disease | Speech Delay | 1.11e-03 | 11 | 135 | 2 | C0241210 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 1.15e-03 | 45 | 135 | 3 | C0011854 | |
| Disease | cholesteryl ester measurement | 1.21e-03 | 257 | 135 | 6 | EFO_0010351 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.21e-03 | 101 | 135 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | Acute kidney injury | 1.21e-03 | 101 | 135 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 1.21e-03 | 101 | 135 | 4 | C1565662 | |
| Disease | obesity (is_marker_for) | 1.21e-03 | 101 | 135 | 4 | DOID:9970 (is_marker_for) | |
| Disease | Kidney Failure, Acute | 1.21e-03 | 101 | 135 | 4 | C0022660 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.22e-03 | 566 | 135 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Pathological accumulation of air in tissues | 1.33e-03 | 12 | 135 | 2 | C0013990 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.33e-03 | 12 | 135 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Essential Hypertension | 1.33e-03 | 12 | 135 | 2 | C0085580 | |
| Disease | Thromboembolism | 1.33e-03 | 12 | 135 | 2 | C0040038 | |
| Disease | familial hyperlipidemia | 1.45e-03 | 106 | 135 | 4 | MONDO_0001336 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.48e-03 | 49 | 135 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Streptozotocin Diabetes | 1.55e-03 | 108 | 135 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.55e-03 | 108 | 135 | 4 | C0011853 | |
| Disease | remnant cholesterol measurement | 1.55e-03 | 108 | 135 | 4 | EFO_0010815 | |
| Disease | Alloxan Diabetes | 1.55e-03 | 108 | 135 | 4 | C0002152 | |
| Disease | Anemia, Hemolytic, Acquired | 1.57e-03 | 13 | 135 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 1.57e-03 | 13 | 135 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 1.57e-03 | 13 | 135 | 2 | C0002889 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 1.57e-03 | 13 | 135 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | Microangiopathic hemolytic anemia | 1.57e-03 | 13 | 135 | 2 | C0221021 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 1.57e-03 | 13 | 135 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.57e-03 | 13 | 135 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.66e-03 | 51 | 135 | 3 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.66e-03 | 51 | 135 | 3 | EFO_0022242 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.66e-03 | 51 | 135 | 3 | EFO_0022285 | |
| Disease | Congestive heart failure | 1.66e-03 | 110 | 135 | 4 | C0018802 | |
| Disease | Heart failure | 1.66e-03 | 110 | 135 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.66e-03 | 110 | 135 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.66e-03 | 110 | 135 | 4 | C0235527 | |
| Disease | Heart Decompensation | 1.66e-03 | 110 | 135 | 4 | C1961112 | |
| Disease | Myocardial Failure | 1.66e-03 | 110 | 135 | 4 | C1959583 | |
| Disease | C-C motif chemokine 19 measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0008047 | |
| Disease | glucose measurement | 1.88e-03 | 380 | 135 | 7 | EFO_0004468 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHGYIISQTGGQLNS | 2576 | Q7Z407 | |
| GIYQVPTGHGTQEQE | 116 | Q14511 | |
| GQPVYQLHSAIGQDQ | 461 | Q9NQ94 | |
| DIYEGQITAILGHNG | 416 | Q8WWZ4 | |
| YVSAQDLPHIENGGV | 211 | O95831 | |
| INQYEPGQGIPAHID | 226 | Q96BT7 | |
| LDQYENHGLVPDGAV | 76 | Q8NEB7 | |
| GVGNQHIPGDNSIYV | 336 | Q12959 | |
| DSGPNGQLDYEIVNG | 2696 | Q6V0I7 | |
| LYEGQITVLLGHNGA | 556 | Q99758 | |
| LIPQLGYVANGDGEV | 616 | Q6RI45 | |
| NLYATEEGPINIGGL | 141 | Q12882 | |
| QDGQVPEQFSGLLHG | 491 | Q92625 | |
| FHPEGGVDLQGYQLD | 16 | Q32M45 | |
| NHGQYLVPDGIAQSQ | 476 | O43307 | |
| GNLHQAQLGGVPGTY | 276 | Q8N1F7 | |
| PEYGQLGHNSDGKFI | 281 | Q9P258 | |
| YGHAGAPNDRTIQNG | 256 | P12955 | |
| GNVQAGDYVLIHAGL | 136 | Q53FA7 | |
| GYLSADQHGQEGLDP | 951 | Q9H0J4 | |
| NNVVLGQYVGNPDGE | 301 | P11413 | |
| EHGYPTINLGIVGDN | 536 | Q9NQX3 | |
| GQSPLHILGQYGKEN | 1006 | Q9P2R3 | |
| DGQGLNYLPGEHLGV | 761 | P35228 | |
| SNLDLQLEYGQGHQG | 371 | Q8IVH8 | |
| DPVGQGYLAHQLLGD | 1316 | P10071 | |
| IINGGINVEIGNPSY | 4481 | Q9NZR2 | |
| TNGHLPGNGDVYQER | 91 | Q86W92 | |
| NGHNPGSDGQAREYL | 6 | Q96H55 | |
| YQHQGGLGSQVSALP | 2871 | Q9UPA5 | |
| VQNEAPALGGGEYQE | 16 | Q5H9J7 | |
| AGPQGSGGNHEQYSL | 151 | P0C7V8 | |
| AQQPLQGGDHSGNYG | 591 | O60506 | |
| GTVGDALHYQLAQIG | 391 | P38570 | |
| GGNPNVHFEILGTNY | 391 | O43424 | |
| AHGYLNLGQIGNLED | 91 | P29122 | |
| QGQEYEAGGSVIHPL | 81 | Q9UHG3 | |
| LGDSQGQLHRVYLGP | 421 | O43157 | |
| NLLLVHYQPGGTAQG | 1521 | Q9H792 | |
| GGQLGELHNGTQYRE | 81 | Q9H1Q7 | |
| GRVNLIGEHTDYNQG | 36 | P51570 | |
| YSEEQLGNVVHGVGL | 191 | Q96J66 | |
| GGHPIVQLHGYLENE | 456 | O95644 | |
| GLGDYLQLHIDQGTV | 1186 | Q9P2S2 | |
| LGGLHNAQQSLPNYG | 236 | O95948 | |
| YAVEIQGQLNGSAGP | 801 | Q7Z7M0 | |
| DVILEVNGYPVGGQN | 511 | Q86UT5 | |
| GIEYIVAQGPTNQGL | 296 | Q86TH1 | |
| GEPGTNGQHAFYQLI | 381 | P06744 | |
| KNQVTIDGLEPGGQY | 536 | Q3SXY7 | |
| GVDLGHIYGDNLERQ | 226 | P23219 | |
| SGQGEPLDDYVNAQG | 16 | Q15195 | |
| LQQEGYEHRGTPVQG | 36 | Q9C0H6 | |
| QGSYIIKQGEPGNHI | 191 | Q13237 | |
| GSQELQYQPGDHLGV | 1026 | P29475 | |
| GGQEGLQYQPGDHIG | 786 | P29474 | |
| HANELNEIDAQPGGY | 3046 | Q5VST9 | |
| NEIDAQPGGYHVLTL | 3051 | Q5VST9 | |
| LGDYLQLHIDQGTVG | 141 | P58401 | |
| NVHDSGEGNIYPELV | 181 | Q9Y5E2 | |
| QPEVLNGNEHLGYGF | 276 | Q9H7U1 | |
| GLDDLGTVYGNIHQQ | 226 | O15072 | |
| HVDGGDGILPRQQYF | 801 | P40189 | |
| AIINYGNSGGPLVNL | 321 | Q92743 | |
| PFQGQGHGAQLLETV | 246 | O14929 | |
| LSHNPEGQQYVEAGT | 451 | Q5T0N1 | |
| HYGGSLPNVNQIGSG | 66 | Q53ET0 | |
| LNAEGRYLQDSHGNP | 1366 | Q4ZHG4 | |
| QPERGLYHLNLTVGG | 411 | Q14393 | |
| LNSAGYLLGPHAVGN | 36 | P22466 | |
| ALSPNYDHVVLGGGQ | 236 | Q13347 | |
| IYHVKDGGPQGFTQQ | 186 | Q6V1X1 | |
| QLQAAGPDGIQVSGY | 296 | Q02318 | |
| VPNYENQDGGSAHQG | 4371 | Q8TDW7 | |
| GVQLPGSYSGHLIAN | 211 | Q9NP62 | |
| TEQRPGVQECYHGNG | 361 | P08519 | |
| TEQRPGVQECYHGNG | 931 | P08519 | |
| DAYEVLNLPQGQGPH | 1301 | O75165 | |
| GGVGNQHIPGDNSIY | 176 | P78352 | |
| NQGLPHGQYSVENAI | 2501 | Q0VDD8 | |
| NGTGYVRHVDNPNGD | 306 | Q9GZT9 | |
| GRSNNPYDLQHIVGG | 191 | Q6GMR7 | |
| IGAPNLLAVGYHNGT | 546 | Q5VTH9 | |
| LHSGEEGTPQYLKGQ | 481 | Q8N6P7 | |
| VDGVLGGEDYNHNNI | 26 | P51808 | |
| HPLTYEGGVDLNSIQ | 531 | Q92636 | |
| QQHGEPGLAQETYAL | 231 | Q96G42 | |
| VNHGVLVVGYGDLNG | 276 | P25774 | |
| NAEIEYNIVPGDGGN | 301 | P55289 | |
| LHGEGQQGDYITLEL | 226 | Q9UHC6 | |
| NISKHGQNNPVGDYE | 41 | Q92674 | |
| LGQPGNLLGNDHIYN | 41 | P00395 | |
| QGLPEGVAFQHPENY | 146 | Q86UP8 | |
| QGLPEGVAFQHPENY | 146 | Q6EKJ0 | |
| GGNYGPTVLVQQEAL | 231 | O15382 | |
| YEQAVDGGPGLHKQV | 786 | O75155 | |
| QGGFEEHLQEAAQGP | 226 | Q5FWE3 | |
| QIAGKTPNDGSYEQH | 596 | Q86YS7 | |
| IDSNGENIGPIYNHR | 1111 | Q01668 | |
| GPEGQHLLQGLEAQF | 526 | Q53GL7 | |
| LEHGADQNIPDEYGN | 226 | B2RU33 | |
| LGQEAAGHLLGEQNY | 581 | Q9P2E2 | |
| AGHLLGEQNYLPQEE | 586 | Q9P2E2 | |
| LPQLGTLGAGNHYAE | 216 | Q9Y3I0 | |
| HYDLVLNGNEIGGGS | 526 | Q6PI48 | |
| GGHYTLQEVEEGLAQ | 131 | P21549 | |
| EHLGYSNGVINGAEL | 1031 | P51531 | |
| HQGGSNDIEGINREY | 796 | Q14DG7 | |
| GQSEYLQQHVAGLQP | 376 | O75157 | |
| ELHYVANELNGIVGG | 421 | Q969Y0 | |
| NNGEGLIDGVHTDYI | 871 | Q06033 | |
| QTSAILQQHYGGDIP | 191 | P78549 | |
| LQQHYGGDIPASVAE | 196 | P78549 | |
| ELVVLGYNGALPNGD | 21 | Q9HAT8 | |
| QIVLGGSDPQHYEGN | 241 | P00797 | |
| GAHGVQVYLPGQGEV | 761 | Q14697 | |
| NDHGELGYQGQLEAR | 106 | P0DPQ3 | |
| EELRHYEAQQGAGGP | 1236 | Q13635 | |
| YEAQQGAGGPAHQVI | 1241 | Q13635 | |
| GVHQYRLQPLQGSGV | 1421 | Q9C0A6 | |
| LPQHYQGAGAGVNGT | 371 | O00570 | |
| VQGDYGALQSNGHPL | 41 | P20265 | |
| HENIQGGGEPFQALY | 1036 | O94875 | |
| GYHNSITEENLPQLG | 1471 | Q9UK61 | |
| LQQFQGPGAQGILDH | 581 | Q15735 | |
| NGDHHGPGNQYLKIQ | 491 | Q7Z2D5 | |
| NGGELILIHQNPGEF | 166 | P23510 | |
| HRALGHYQPQGDQGE | 141 | A2A3L6 | |
| PVSGNLIDLYGNQGL | 256 | O75030 | |
| YTELLQEHGPQGLNE | 936 | Q9UJ98 | |
| YQLHGAEVNGGLPSA | 276 | P15923 | |
| LPLYHSAGNIVGIGQ | 286 | Q6P1M0 | |
| PHYDGIEALTIQGDN | 1541 | Q7Z4S6 | |
| QIPGYIDGVNFNPEH | 981 | O94759 | |
| LADINVDGPENGYGH | 441 | Q9NUY8 | |
| DTNPNFQIIIGYHGG | 2391 | Q6N022 | |
| HQGGLVPGLEYLEQV | 431 | Q86VD9 | |
| ENGHRYQANLEITGP | 866 | Q96AE7 | |
| TGLHYKPTEQFNGQG | 326 | Q8NF64 | |
| GELGSLHSQLGNYEQ | 961 | Q96AY4 | |
| QASDYGINHAQLPLG | 221 | Q8TBZ6 | |
| RLQNGPIGQYGAAEE | 101 | P36406 | |
| EISQGQGHSVTYPLG | 121 | Q96PF1 | |
| LHSGADIQQVGYGGL | 121 | Q59H18 | |
| QQYLNEIVGGQEPGE | 136 | Q99633 | |
| QAGSEGQLLPQHYLN | 1491 | Q7Z3T8 | |
| LLQGVHQGAGFQDIP | 41 | Q15631 | |
| VGVLNNLLYAVGGHD | 491 | O95198 | |
| GEDQIYEAHQQGRGA | 151 | Q8WU39 |